HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Marit Synnestvedt Selected Research

Marit Synnestvedt Research Topics

Disease

9Breast Neoplasms (Breast Cancer)
01/2021 - 04/2008
7Neoplasms (Cancer)
01/2017 - 09/2007
1Neoplasm Metastasis (Metastasis)
01/2017

Drug/Important Bio-Agent (IBA)

2Docetaxel (Taxotere)FDA Link
12/2014 - 07/2014
2Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
09/2012 - 02/2011
2Phenobarbital (Luminal)FDA Link
02/2011 - 09/2007
14-hydroxy-N-desmethyltamoxifenIBA
01/2021
1Estrogen ReceptorsIBA
01/2021
1TamoxifenFDA LinkGeneric
01/2021
1Proteins (Proteins, Gene)FDA Link
01/2017
1Fluorouracil (Carac)FDA LinkGeneric
12/2014
1Epirubicin (Ellence)FDA LinkGeneric
12/2014
1Biomarkers (Surrogate Marker)IBA
12/2014
1Cyclophosphamide (Cytoxan)FDA LinkGeneric
12/2014
1Messenger RNA (mRNA)IBA
07/2014
1Mammaglobin AIBA
07/2014
1Keratin-19 (Keratin 19)IBA
07/2014
1Cyclooxygenase 2 (Cyclooxygenase-2)IBA
10/2012
1Progesterone Receptors (Progesterone Receptor)IBA
10/2012
1Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA
09/2012
1Vascular Endothelial Growth Factor Receptor-1 (fms-Like Tyrosine Kinase)IBA
09/2012
1Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA
09/2012
1Indicators and Reagents (Reagents)IBA
05/2011
1AntibodiesIBA
02/2011
1Hormones (Hormone)IBA
02/2011
1Keratins (Keratin)IBA
02/2011

Therapy/Procedure

3Therapeutics
01/2017 - 04/2008
1Drug Therapy (Chemotherapy)
12/2014